Mouthwash may tame tender gums, new study hopes
NCT ID NCT07551908
First seen Jun 27, 2026 · Last updated Aug 27, 2026 · Updated 2 times
Summary
This study tests whether a special mouthwash can reduce gum inflammation (gingivitis) in adults. Thirty healthy volunteers with moderate gum redness and swelling will rinse daily for 4 weeks. Dentists will check their gums at the start and end to see if the product helps ease symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
33 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
Jul 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Healthy male and female subjects (with no specific repartition) 2. Subjects of Caucasian ethnicity 3. Subjects aged between 18 and 65 years (extremes included) 4. Subjects clinically showing moderate gums inflammation (gingivitis grade II, in particular all gingival scores for the mean should be between 1.75 and 2.3, according to Löe and Silness gingival scoring system), in particular: 1. 20% of the subjects with localized gingivitis (10-30% of evaluated sites with bleeding) 2. 80% of them with generalized gingivitis (\>30% of evaluated sites with bleeding) 5. Subjects with dental plaque (total plaque score at inclusion ≥2) 6. Subjects registered with the national health service 7. Subjects certifying the truthfulness of the personal data disclosed to the Principal Investigator or designated personnel 8. Subjects able to understand the language used in the investigation centre and the information given by the Principal Investigator or designated personnel 9. Subjects able to respect the instructions given by the Principal Investigator or designated personnel as well as able to respect the study constraints and specific requirements 10. Subjects who commit not to change their daily routine or lifestyle during the study 11. Subjects on stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study 12. Subjects informed about the test procedures who have signed a consent form and privacy agreement Exclusion Criteria: 1. Subjects who do not meet the inclusion criteria 2. Smokers subjects 3. Subjects planning toothcare during the study period 4. Subjects using dental apparatus or using dental prosthesis, with generalized tooth recession, with presence of caries, with dental abscess or signs of periodontitis (periodontal probing depth \>3mm) or active periodontitis 5. Subjects using other dental hygiene products than provided (e.g. dental floss, interdental brushes, mouthwash, etc) during the study period 6. Subjects with any acute, chronic, or progressive disease or condition that may interfere with the study data or that the Principal Investigator considers dangerous to the subject or incompatible with the requirements of the study 7. Subjects participating or planning to participate in other clinical trials 8. Subjects who participated in a similar study without respecting an adequate washout period (at least one month) 9. Subjects that have intolerances or allergies to ingredients of the study product Page 8 of 28 Clinical Study Protocol: EC\_0000149/2026 of 13/03/2026 10. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the Principal Investigator 11. Subjects who are currently using products with the same activity as the study product, or who haven't observed an adequate washout period (at least one month) 12. Subjects admitted to a health or social facility 13. Subjects planning a hospitalization during the study 14. Subjects not able to be contacted in case of emergency 15. Subjects deprived of freedom by administrative or legal decision or under guardianship 16. Subjects who have or have had a history of alcohol or drug addiction 17. Subjects with eating disorders (i.e. bulimia, psychogenic eating disorders, etc.) 18. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gingivitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Dental Rob
Badalona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Seeing your gums in 3D: can personalized images spark better brushing?
- Gum fluid holds clues to Behçet's disease puzzle
- Can a special toothpaste tame gum disease?
- Could a toothbrush and mouthwash cut pneumonia in the elderly?
- Electric flosser may tackle plaque and gum bleeding better than brushing alone
- Braces vs. clear aligners: which is gentler on your gums?